SEC Form 4 · accession 0000904454-17-000311
Esperion Therapeutics, Inc. · ESPR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicole Vitullo
Director · 10% Owner
Period of report
Apr 17, 2017
Accepted (ET)
Apr 19, 2017 · 4:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434868
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $38.96 | Apr 17, 2017 | A | 14,000 | A | — | Apr 17, 2027 | Common Stock | 14,000 | 14,000 | D |
Explanation of responses
- F1The option vests in full on the earlier of (i) April 17, 2018 or (ii) the Issuer's next annual meeting of stockholders following April 17, 2017, subject to the Reporting Person's continued service on the Board of Directors at such time.